パルスオキシメーター装置:医療機器パイプライン分析2018

GlobalDataが発行した調査報告書(GDME0512EPD)
◆英語タイトル:Pulse Oximeter Systems - Medical Devices Pipeline Assessment, 2018
◆商品コード:GDME0512EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年3月1日
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Pulse Oximeter Systems – Medical Devices Pipeline Assessment, 2018
Summary

GlobalData’s Medical Devices sector report, “Pulse Oximeter Systems – Medical Devices Pipeline Assessment, 2018″ provides an overview of Pulse Oximeter Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pulse Oximeter Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Pulse Oximeter Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Pulse Oximeter Systems and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Pulse Oximeter Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Pulse Oximeter Systems Overview 8
3 Products under Development 9
3.1 Pulse Oximeter Systems – Pipeline Products by Stage of Development 9
3.2 Pulse Oximeter Systems – Pipeline Products by Segment 10
3.3 Pulse Oximeter Systems – Pipeline Products by Territory 11
3.4 Pulse Oximeter Systems – Pipeline Products by Regulatory Path 12
3.5 Pulse Oximeter Systems – Pipeline Products by Estimated Approval Date 13
3.6 Pulse Oximeter Systems – Ongoing Clinical Trials 14
4 Pulse Oximeter Systems – Pipeline Products under Development by Companies 15
4.1 Pulse Oximeter Systems Companies – Pipeline Products by Stage of Development 15
4.2 Pulse Oximeter Systems – Pipeline Products by Stage of Development 16
5 Pulse Oximeter Systems Companies and Product Overview 17
5.1 Advanced Medical Electronics Corp Company Overview 17
5.1.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Cactus Semiconductor Inc Company Overview 18
5.2.1 Cactus Semiconductor Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 City, University of London Company Overview 19
5.3.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Dartmouth College Company Overview 21
5.4.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Intelligent Optical Systems, Inc. Company Overview 23
5.5.1 Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.6 Koronis Biomedical Technologies Corporation Company Overview 24
5.6.1 Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Masimo Corp Company Overview 25
5.7.1 Masimo Corp Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 Medtronic plc Company Overview 34
5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
5.9 Rice University Company Overview 39
5.9.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 39
5.10 Safe Heart USA Inc Company Overview 40
5.10.1 Safe Heart USA Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.11 Stellenbosch University Company Overview 41
5.11.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 41
5.12 Technical University of Denmark Company Overview 42
5.12.1 Technical University of Denmark Pipeline Products & Ongoing Clinical Trials Overview 42
5.13 The City College of New York Company Overview 43
5.13.1 The City College of New York Pipeline Products & Ongoing Clinical Trials Overview 43
5.14 True Wearables, Inc. Company Overview 45
5.14.1 True Wearables, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.15 University of British Columbia Company Overview 46
5.15.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 46
5.16 University of California Berkeley Company Overview 47
5.16.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 47
5.17 Wipox LLC Company Overview 48
5.17.1 Wipox LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.18 Xhale Inc Company Overview 49
5.18.1 Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview 49
6 Pulse Oximeter Systems- Recent Developments 50
6.1 Feb 09, 2018: BioScrip Announces U.S. Congress Passage of Medicare Home Infusion Transition Benefit, Effective 2019 50
6.2 Feb 08, 2018: Cardinal Health Reports Second-quarter Results for Fiscal Year 2018 50
6.3 Feb 07, 2018: Masimo Announces CE Marking of Eve CCHD Newborn Screening Application for the Rad-97 Pulse CO-Oximeter 52
6.4 Feb 07, 2018: Cardinal Health Adds Akhil Johri to its Board of Directors 52
6.5 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results 53
6.6 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic’s Greater China Region 54
6.7 Jan 29, 2018: Getinge Reported Net Sales Of SEK22,495 M In 2017 55
6.8 Jan 18, 2018: Advanced Micronic Devices: Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) regulation 2015 56
6.9 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 56
6.10 Jan 09, 2018: Masimo Announces FDA Clearance for Home Use of Rad-97 56
6.11 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer 56
6.12 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic’s Asia Pacific Region 57
6.13 Dec 05, 2017: Screening for Critical Congenital Heart Disease at Birth Saves Lives 58
6.14 Dec 04, 2017: New Findings: Superior Home-Monitoring Technology Improves Usability, Care Access, and Reduces Parental Anxiety in Newborns 59
6.15 Dec 01, 2017: Artemis Hospital Becomes First in India to Adopt Masimo Patient SafetyNet Across All Hospital Care Areas 60
6.16 Nov 27, 2017: Masimo Announces FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines 61
6.17 Nov 21, 2017: Medtronic Reports Second Quarter Financial Results 62
6.18 Nov 10, 2017: Revised strategy, new financial targets and restated financial information for Getinge (excluding Arjo) 64
6.19 Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue 66
6.20 Nov 07, 2017: Masimo Announces Distribution of Rad-57 Pulse CO-Oximeters by The Jeffrey Lee Williams Foundation to First Responders 67
6.21 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018 68
6.22 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan 69
6.23 Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report 72
6.24 Nov 02, 2017: CONMED Announces Retirement of Chief Financial Officer 73
6.25 Nov 02, 2017: CONMED Announces Third Quarter 2017 Financial Results 73
6.26 Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya 75
6.27 Oct 31, 2017: Masimo Reports Third Quarter 2017 Financial Results 75
6.28 Oct 18, 2017: Getinge publish Interim Report January – September 2017 76
6.29 Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria 76
6.30 Sep 26, 2017: Getinge Appoints Interim CFO 78
6.31 Sep 18, 2017: Masimo Announces FDA Clearance And Full Market Release Of Rad-97 Pulse CO-Oximeter 78
6.32 Sep 14, 2017: Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000 Health Workers through Newborn Screening Initiative in Support of Every Woman Every Child 79
6.33 Sep 11, 2017: An opportunity to evaluate and speed-up new projects – Meet GE Healthcare at the Uppsala BIO booth 80
6.34 Sep 06, 2017: A New Approach to treating Obstructive Sleep Apnea: Dentsply Sirona and Zephyr Sleep Technologies announce strategic partnership 81
6.35 Sep 05, 2017: Study Evaluates Performance of Masimo iSpO2 Rx Smart Device-Paired Pulse Oximeter in Screening Newborns for Critical Congenital Heart Disease 82
6.36 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 82
6.37 Aug 21, 2017: Study Investigates Performance of Masimo PVi As Part of Goal-Directed Fluid Therapy During Laparoscopic Bariatric Surgery 85
6.38 Aug 11, 2017: New Retail Director joins Drive DeVilbiss 86
6.39 Aug 03, 2017: Getinge to cooperate with Brazilian authorities on local ongoing investigations 86
6.40 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 87
6.41 Aug 02, 2017: Masimo Reports Second Quarter 2017 Financial Results 88
6.42 Jul 31, 2017: Study Compares Performance of Masimo Acoustic Respiration Rate and Nellcor Plethysmographic Respiration Rate in Volunteers 89
6.43 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 89
6.44 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 90
6.45 Jul 17, 2017: Getinge appoints Lars Sandstrom as CFO and Member of Getinge Executive Team 91
6.46 Jul 17, 2017: Getinge has replanned the remediation in Hechingen (DE) related to the Consent Decree with FDA and makes a provision of additional SEK 488 M 92
6.47 Jul 17, 2017: Getinge: Interim Report January – June 2017 92
6.48 Jul 13, 2017: Nihon Kohden Selected for FTSE4Good Index Series and FTSE Blossom Japan Index 92
6.49 Jul 10, 2017: Masimo Announces CE Marking of rainbow Super Sensor 93
6.50 Jun 29, 2017: Visit Our New Hybrid Operating Room at Getinge Experience Center 94
6.51 Jun 24, 2017: Investigation by the Brazilian Administrative Council for Economic Defense comprises two Getinge entities 94
6.52 Jun 13, 2017: Nihon Kohden to reorganize its group companies in India 94
6.53 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 95
6.54 Jun 08, 2017: Edan Intelligent-made Move Forward to the World The 77th CMEF exhibition 96
6.55 Jun 05, 2017: Masimo Announces Market Release of Rad-67 rainbow Pulse CO-Oximeter with Next Generation SpHb 97
6.56 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 97
6.57 May 16, 2017: EDAN Exhibited at Hospitalar 2017 100
6.58 May 09, 2017: Masimo Introduces Rad-G Pulse Oximeter 101
6.59 May 03, 2017: Masimo Reports First Quarter 2017 Financial Results 102
6.60 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 103
6.61 Apr 26, 2017: CONMED Announces First Quarter 2017 Financial Results 104
6.62 Apr 25, 2017: Getinge: Interim Report January-March 2017 105
6.63 Apr 20, 2017: Chief Financial Officer leaves Getinge 105
6.64 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 105
6.65 Mar 29, 2017: Resolutions at Getinge’s Annual General Meeting 2017 106
6.66 Mar 21, 2017: The new Getinge logo – inspired by the star of life 107
6.67 Mar 20, 2017: Masimo Announces CE Marking of Rad-97 Pulse CO-Oximeter and Connectivity Hub with Noninvasive Blood Pressure 107
6.68 Mar 20, 2017: Getinge establishes new brand structure and becomes a single brand company 108
6.69 Mar 15, 2017: Getinge to exhibit full product portfolio for Intensive Care Units at International Symposium on Intensive Care and Emergency Medicine (ISICEM) 108
6.70 Mar 08, 2017: Connecting Career Potential and Company Leadership Earned Cardinal Health Distinction from National Association for Female Executives 109
6.71 Feb 27, 2017: New Study Assesses the Utility of Masimo PVi Monitoring During Colorectal Surgery 109
6.72 Feb 21, 2017: Taiwan Biophotonic Receives CE Mark to Launch World’s First Medical Smart Watch for Monitoring Heart Rate and Blood Oxygen 110
6.73 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 112
7 Appendix 115
7.1 Methodology 115
7.2 About GlobalData 118
7.3 Contact Us 118
7.4 Disclaimer 118

1.1 List of Tables
Table 1: Pulse Oximeter Systems - Pipeline Products by Stage of Development 9
Table 2: Pulse Oximeter Systems - Pipeline Products by Segment 10
Table 3: Pulse Oximeter Systems - Pipeline Products by Territory 11
Table 4: Pulse Oximeter Systems - Pipeline Products by Regulatory Path 12
Table 5: Pulse Oximeter Systems - Pipeline Products by Estimated Approval Date 13
Table 6: Pulse Oximeter Systems - Ongoing Clinical Trials 14
Table 7: Pulse Oximeter Systems Companies - Pipeline Products by Stage of Development 15
Table 8: Pulse Oximeter Systems - Pipeline Products by Stage of Development 16
Table 9: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Continuous Pulse Oximeter - Neonatal Monitoring - Product Status 17
Table 11: Continuous Pulse Oximeter - Neonatal Monitoring - Product Description 17
Table 12: Cactus Semiconductor Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 13: Pulse Oximetry Device - Product Status 18
Table 14: Pulse Oximetry Device - Product Description 18
Table 15: City, University of London Pipeline Products & Ongoing Clinical Trials Overview 19
Table 16: Ear Canal Pulse Oximetry Probe - Product Status 19
Table 17: Ear Canal Pulse Oximetry Probe - Product Description 19
Table 18: Fibre-Optic Sensor - Product Status 20
Table 19: Fibre-Optic Sensor - Product Description 20
Table 20: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 21
Table 21: Non-Invasive pO2 Measurement Device - Product Status 21
Table 22: Non-Invasive pO2 Measurement Device - Product Description 21
Table 23: Oxygen-Sensing Chip - Product Status 22
Table 24: Oxygen-Sensing Chip - Product Description 22
Table 25: Intelligent Optical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: Pulse Oximeter For Newborn Screening - Product Status 23
Table 27: Pulse Oximeter For Newborn Screening - Product Description 23
Table 28: Koronis Biomedical Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
Table 29: Low Power Wireless Pulse Oximeter Sensor - Product Status 24
Table 30: Low Power Wireless Pulse Oximeter Sensor - Product Description 24
Table 31: Masimo Corp Pipeline Products & Ongoing Clinical Trials Overview 25
Table 32: iSpO2 Rx - Product Status 25
Table 33: iSpO2 Rx - Product Description 26
Table 34: Masimo rainbow SET - SpfO2 - Product Status 26
Table 35: Masimo rainbow SET - SpfO2 - Product Description 26
Table 36: Rad-67 Rainbow Pulse CO-Oximeter - Product Status 27
Table 37: Rad-67 Rainbow Pulse CO-Oximeter - Product Description 27
Table 38: Rad-G - Product Status 27
Table 39: Rad-G - Product Description 28
Table 40: rainbow Super DCI-mini sensor - Product Status 28
Table 41: rainbow Super DCI-mini sensor - Product Description 28
Table 42: rainbow Super DCI-mini sensor - Continuous Measurement Version - Product Status 29
Table 43: rainbow Super DCI-mini sensor - Continuous Measurement Version - Product Description 29
Table 44: Rainbow Universal ReSposable SuperSensor - Product Status 29
Table 45: Rainbow Universal ReSposable SuperSensor - Product Description 30
Table 46: SpHb Spot Check Pronto - Product Status 30
Table 47: SpHb Spot Check Pronto - Product Description 30
Table 48: Masimo Corp - Ongoing Clinical Trials Overview 31
Table 49: SpHb Spot Check Pronto - Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic 32
Table 50: SpHb Spot Check Pronto - Optimal Time for Postpartum Hemoglobin Assessment and its Correlation with Estimated Blood Loss (EBL)/Quantitative Blood Loss (QBL) and Noninvasive Hemoglobin Spot Check 32
Table 51: Rad-67 Rainbow Pulse CO-Oximeter - Non-invasive Spot Hemoglobin Measurement in the Outpatient Obstetric Clinic 33
Table 52: Rad-67 Rainbow Pulse CO-Oximeter - Prevalence of Anemia in Orthopedic Surgery, Data Collection From Classical Laboratory Determination of Hemoglobin, by Non-invasive Hemoglobin Measurement (Rad-67) and by HemoCue 33
Table 53: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 54: INVOS System - Cerebral Autoregulation - Product Status 34
Table 55: INVOS System - Cerebral Autoregulation - Product Description 34
Table 56: Pulse Oximeter With Universal Sensor - Product Status 35
Table 57: Pulse Oximeter With Universal Sensor - Product Description 35
Table 58: Medtronic plc - Ongoing Clinical Trials Overview 36
Table 59: INVOS System - Cerebral Autoregulation - Correlating Brain Tissue Oxygen Tension (PbrO2) and Regional Cerebral Oximetry (rSO2) in Normal Human Brain Under the Conditions of Changing Ventilation Strategy 37
Table 60: INVOS System - Cerebral Autoregulation - Effect of the Prevena Incision Management System on Sternal Wound Edge Perfusion in Patients Undergoing CABG With Bilateral Mammary Artery Grafts 37
Table 61: INVOS System - Cerebral Autoregulation - Effects of the Prone and the Sitting Positions on the Brain Oxygenation in Posterior Fossa Surgery 37
Table 62: INVOS System - Cerebral Autoregulation - Influence of Volume Optimization on Cognitive Function in Major Abdominal Surgery 38
Table 63: Rice University Pipeline Products & Ongoing Clinical Trials Overview 39
Table 64: Luminox - Product Status 39
Table 65: Luminox - Product Description 39
Table 66: Safe Heart USA Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 67: Pediatric iOximeter - Product Status 40
Table 68: Pediatric iOximeter - Product Description 40
Table 69: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 41
Table 70: Artificial Pulse Oximeter - Product Status 41
Table 71: Artificial Pulse Oximeter - Product Description 41
Table 72: Technical University of Denmark Pipeline Products & Ongoing Clinical Trials Overview 42
Table 73: O2Matic Robot - Product Status 42
Table 74: O2Matic Robot - Product Description 42
Table 75: The City College of New York Pipeline Products & Ongoing Clinical Trials Overview 43
Table 76: Wireless Intraoperative Pulse Oximeter - Product Status 43
Table 77: Wireless Intraoperative Pulse Oximeter - Product Description 43
Table 78: Wireless Pulse Oximetry - Product Status 44
Table 79: Wireless Pulse Oximetry - Product Description 44
Table 80: True Wearables, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 81: Oxxiom - Product Status 45
Table 82: Oxxiom - Product Description 45
Table 83: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 46
Table 84: Camera Oximeter - Product Status 46
Table 85: Camera Oximeter - Product Description 46
Table 86: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 47
Table 87: Pulse Oximeter Sensor - Product Status 47
Table 88: Pulse Oximeter Sensor - Product Description 47
Table 89: Wipox LLC Pipeline Products & Ongoing Clinical Trials Overview 48
Table 90: WiPOX - Product Status 48
Table 91: WiPOX - Product Description 48
Table 92: Xhale Inc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 93: Respiratory Oximeter - Product Status 49
Table 94: Respiratory Oximeter - Product Description 49
Table 95: Glossary 117

1.2 List of Figures
Figure 1: Pulse Oximeter Systems - Pipeline Products by Stage of Development 9
Figure 2: Pulse Oximeter Systems - Pipeline Products by Segment 10
Figure 3: Pulse Oximeter Systems - Pipeline Products by Territory 11
Figure 4: Pulse Oximeter Systems - Pipeline Products by Regulatory Path 12
Figure 5: Pulse Oximeter Systems - Pipeline Products by Estimated Approval Date 13
Figure 6: Pulse Oximeter Systems - Ongoing Clinical Trials 14

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ パルスオキシメーター装置:医療機器パイプライン分析2018(Pulse Oximeter Systems - Medical Devices Pipeline Assessment, 2018)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆